Search

everythinglearnresearchcommunity

for

Search:↓

CGF therapy may effectively treat psoriasis by reducing inflammation.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Understanding how EDC genes are regulated can help develop better drugs for skin diseases.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

New genetic factors linked to acne risk were discovered, highlighting the role of certain pathways and genes.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

The meeting highlighted major advances in skin research, including new findings on skin microbes, genetic links to skin diseases, and improved treatments for various conditions.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Both human and animal-derived small extracellular vesicles speed up skin healing equally well.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

High androgen levels can cause hirsutism and increase inflammation.

People with alopecia have a higher risk of thyroid cancer.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Japanese researchers created new hair follicles from human cells that grew hair when put into mice, and other findings showed a link between eye disease severity and corneal thickness, gene mutations affecting hearing and touch, and the safety of the shingles vaccine for adults over 50.

Testosterone may worsen hair loss by affecting hair growth signals, while different prostaglandins can either hinder or promote hair growth.

Removing both Atr and Trp53 genes in adult mice causes severe tissue damage and death due to DNA damage.

Multiple treatments work best for hair loss.

Androgens may block hair growth signals, targeting this could treat hair loss.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

Scientists developed a new method to deliver alopecia treatment directly to hair follicles, which could be a promising treatment for hair loss and other hair diseases.

LLLT helps treat hair loss by increasing blood flow, reducing inflammation, and stimulating growth factors.

The study identified key genes and pathways that influence goat wool quality and growth.

Removing the Crif1 gene in mouse skin disrupts skin balance and hair growth.

Mice without the vitamin D receptor gene lose hair due to disrupted hair follicle cycles.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

The conclusion suggests a possible link between iron levels and hair health in women, recommending further research on iron supplementation for hair loss.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.